I focus on end‑to‑end process analytics for continuous pharmaceutical manufacturing—integrating PAT and spectroscopy with hybrid first‑principles and data‑driven models to automate chemical data analysis, enable real‑time quality assurance, and speed disturbance detection and root‑cause analysis.